Pharmacologic treatments for covid-19 patients
High dose Interferon-Beta 1a vs Low dose Interferon-Beta 1a
This comparison will not be updated. Last search date 14 Dec, 2022
Hospitalized patients
Forest plots
(last update: 2021-03-04)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=215
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04521400 Darazam IA, Int Immunopharmacol, 2021 Full text Full text Commentary |
Public/non profit |
Interferon beta 1-a High dose |
Interferon beta 1-a Low dose |
RCT | Patients with T-PCR and/or chest CT confirmed COVID-19 (moderate-severe) admitted to a single center in Iran. | N=168 |
Some concerns Details |
|